ID: PMRREP3064| 188 Pages | 21 Nov 2025 | Format: PDF, Excel, PPT* | Healthcare
The global compression therapy devices market size is likely to value from US$4.3 billion in 2025 and projected to reach US$5.4 billion at a CAGR of 3.2% during the forecast period from 2025 to 2032.
The rising prevalence of varicose veins, lymphedema, and venous ulcers, and an increasing awareness about advanced wound management and post-surgical recovery solutions further boost the adoption of compression therapy devices. Technological advancements, such as portable pneumatic pumps and smart compression garments, enhance patient comfort and treatment efficiency.
Growing demand for home-based care and non-invasive therapies also contributes to market expansion. Moreover, the aging population and sedentary lifestyles have elevated cases of venous disorders, fueling product demand.
| Key Insights | Details |
|---|---|
| Compression Therapy Devices Market Size (2025E) | US$4.3 Bn |
| Market Value Forecast (2032F) | US$5.4 Bn |
| Projected Growth (CAGR 2025 to 2032) | 3.2% |
| Historical Market Growth (CAGR 2019 to 2024) | 1.6% |

The rising incidence of venous and lymphatic disorders such as varicose veins, deep vein thrombosis (DVT), and lymphedema has become a major factor boosting the demand for compression therapy devices globally. Sedentary lifestyles, obesity, and prolonged standing or sitting contribute to poor blood circulation, leading to these chronic conditions.
Compression therapy is increasingly recommended as the first-line, non-invasive treatment to enhance venous return, reduce swelling, and prevent clot formation. The growing awareness among patients and clinicians about early diagnosis and preventive care has further accelerated product adoption.
Moreover, the rising number of elderly individuals and post-surgical patients prone to venous insufficiency continues to create a strong clinical need for effective and comfortable compression solutions across healthcare settings.
Although the compression therapy market has numerous end-uses, certain obstacles are likely to stymie market growth. Given the high sales and demand for compression therapy devices around the world, regulatory authorities are further inspecting the industry and passing new laws requiring strict guidelines to be followed when manufacturing medical compression garments.
Parameters such as optimal therapeutic efficacy, product reliability, and best comfort must be present for patients with skin problems or wounds.
Furthermore, there is a global lack of international standards for compression therapy products in terms of certain parameters, such as garment selection or pressure standards for the treatment of specific diseases. The German RAL, French ASQUL, and British standards each have their own pressure standards, whereas the US FDA does not specify a pressure standard. As a result, varying product efficacy can lead to a loss of customer trust and limit market growth.
The growth in post-surgical rehabilitation presents a significant opportunity for the compression therapy devices market. Following orthopedic, vascular, and cosmetic surgeries, patients often experience swelling, edema, and reduced blood circulation, which can delay recovery. Compression therapy devices help minimize these complications by improving venous return and controlling postoperative inflammation.
Surgeons increasingly recommend compression garments and pumps as part of recovery protocols to enhance healing outcomes and prevent deep vein thrombosis (DVT). The growing number of surgical procedures worldwide, coupled with greater awareness of non-invasive rehabilitation aids, is driving the adoption of compression therapy devices in both hospitals and home-care settings.
Compression garments, including stockings and sleeves, hold the highest market share in the compression therapy devices market due to their affordability, ease of use, and widespread clinical acceptance. These garments offer consistent, controlled pressure to improve blood flow, reduce swelling, and prevent venous disorders such as varicose veins and lymphedema.
They are non-invasive, reusable, and available in various compression levels, making them suitable for both hospital and home use. Physicians often recommend them as the first-line treatment for venous insufficiency and post-surgical recovery.
Additionally, advancements in breathable, skin-friendly fabrics and stylish designs have increased patient comfort and compliance, further boosting their global adoption across preventive care, chronic disease management, and rehabilitation applications.
Static compression therapy holds the highest market share in the compression therapy devices market because it offers simple, effective, and affordable treatment options. Using garments and bandages, this therapy provides consistent pressure to enhance blood circulation and reduce swelling in venous and lymphatic disorders.
Its non-invasive nature, ease of application, and suitability for long-term use make it highly preferred by both healthcare professionals and patients. Static compression products require no electrical components, making them convenient for home care and low-resource settings. Their proven clinical effectiveness, wide availability, and strong physician recommendation further strengthen their dominance in the global compression therapy market.

North America, particularly the United States, leads the global compression therapy devices market due to its advanced healthcare infrastructure, high disease awareness, and strong adoption of non-invasive treatment solutions. The region’s growing prevalence of venous disorders, obesity, and lymphedema drives continuous demand for products.
Widespread availability of compression garments, pumps, and smart wearable devices supports both clinical and home-care applications. Moreover, favorable reimbursement policies, strong physician recommendations, and technological advancements from leading U.S. manufacturers enhance market penetration.
Increased use of compression therapy in post-surgical rehabilitation and sports recovery further solidifies North America’s dominant position in the global compression therapy devices industry.
The Asia-Pacific region is emerging as the fastest-growing market for compression therapy devices, driven by rising healthcare awareness, expanding medical infrastructure, and an increasing number of cases of venous and lymphatic disorders. Countries such as India, China, and Japan are witnessing higher adoption of compression garments and pumps due to growing aging populations and lifestyle-related diseases.
Rapid urbanization and improved access to advanced wound care solutions further boost market growth. Additionally, local manufacturing initiatives and affordable product offerings are expanding accessibility. Increasing post-surgical applications, government healthcare programs, and physician training on compression therapy are strengthening the Asia Pacific’s position as a key emerging market.

The compression therapy devices market features a competitive landscape marked by continuous innovation and technological advancements. Manufacturers are focusing on developing smart, lightweight, and patient-friendly compression systems to enhance therapy outcomes and comfort.
Companies are expanding their global reach through strategic partnerships, product launches, and regulatory approvals. The growing demand for home-care solutions and portable compression devices is encouraging product diversification and price competitiveness.
The global compression therapy devices market is projected to be valued at US$4.3 Bn in 2025.
The Global Compression Therapy Devices Market is driven by the rising prevalence of venous and lymphatic disorders, the growing aging population, and the increasing demand for non-invasive treatment options.
The global market is poised to witness a CAGR of 3.2% between 2025 and 2032.
Key market opportunities include the development of smart wearable compression devices, expansion in home healthcare settings, and growing use in sports recovery.
Mölnlycke Health Care AB, 3M, Brownmed, Inc., Cardinal Health., Daesung Maref Co., Ltd, and others.
| Report Attribute | Details |
|---|---|
| Historical Data/Actuals | 2019 - 2024 |
| Forecast Period | 2025 - 2032 |
| Market Analysis | Value: US$ Mn, Volume: Units |
| Geographical Coverage |
|
| Segmental Coverage |
|
| Competitive Analysis |
|
| Report Highlights |
|
By Product
By Technology
By Application
By Distribution Channel
By Region
Delivery Timelines
For more information on this report and its delivery timelines please get in touch with our sales team.
About Author